Teva
Highly Engaged Employees
Manufacturing · Israel · 10K+ Employees
View Company Info for Free
Overview
Headquarters
124 Dvora Hanevi'a St, Tel Aviv, Tel Avi...Phone Number
+972 39148213Website
www.tevapharm.comRevenue
$17.3 BillionStock Symbol
TEVAIndustry
About Teva
Teva Org Chart
Commercial & Data , International Markets Gen...
Head of Labor & Employment, International Mar...
Global Regulatory Compliance Senior Director,...
General Counsel
IP Litigation Vice President & General Counse...
Senior Director, Legal & LATAM General Counse...
Vice President General Counsel, Global Commer...
Senior Director, General Counsel, Research an...
Sle Salomon Levin & Elstein Ltd General Couns...
Is Teva your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Teva recently announced quarterly report
Click to see if Teva had a recent Job posting/layoffs
Teva, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Teva
Funding: Get notified immidiatlly once Teva has new funding data
Check out if Teva is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Teva launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Teva has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Teva
Find more new buyers
Compare Similar Companies to Teva
Compare insights from companies similar to Teva, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Teva
Company Profile Activity
Activity Insights
Teva is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Teva is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Teva.
Teva financials insights
Gather financial insights about Teva, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Multiple Rounds
$11.3B
Multiple Rounds
$7.6B
Debt
$2.4B
Debt
$33.8B
Multiple Rounds
$28.1B
Corporate Investment
$358M
Debt
$4.5B
Debt
$2.3B
Private Equity
$400M
Teva Tech Stack
A closer look at the technologies used by Teva
Most Recent Scoops
Teva News & Media
Teva to Present at the Goldman Sachs Global Healthcare Conference
PARSIPPANY, N.J., and TEL AVIV, Israel, June 01, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Monday, June 8, 2026. The fireside chat will begin at 8:00 A.M. Eastern Time.Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution
TEL AVIV, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Fitch Ratings Agency (“Fitch”) has raised the Company's corporate credit rating to Investment Grade BBB-, with a stable outlook, from BB+.Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact
PARSIPPANY, N.J. and TEL AVIV, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new data from the ongoing, real-world IMPACT-TD Registry, highlighting a significant gap in diagnosing tardive dyskinesia (TD) in patients with underlying mood disorders. While the findings demonstrate that most patients across all age groups experience multidimensional impact from the condition, young adultsTeva Pharmaceutical (TEVA) Reports Q1 Beat, Plans Amylyx Deal
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best Middle East and Africa stocks to buy according to hedge funds. On April 29, Teva Pharmaceutical Industries Limited (NYSE:TEVA) reported its Q1 FY2026 earnings, where it revealed that revenue was $4.0 billion for the quarter. This is a 2% year over year increase and a […]
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Teva
Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical leader focused on improving health outcomes for patients worldwide. Enabled by a world-class generics business, Teva develops, manufactures, and delivers a broad portfolio of medicines, including complex generics, biosimilars, innovative therapies, and pharmacy brands. The company is... Read More
